Vontobel Holding
AQST icon

Vontobel Holding’s Aquestive Therapeutics AQST Stock Holding History

Vontobel Holding’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-14,000
Closed -$36.4K – 1081
2024
Q2 		$36.4K Buy
+14,000
New +$46.8K ﹤0.01% 1052

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

Vontobel Holding's AQST Position: Q3 2024 in Review

Vontobel Holding sold out of Aquestive Therapeutics (AQST) in Q3 2024, closing a stake of 14,000 shares — an estimated $36.4K sold.

Vontobel Holding first reported a position in AQST in Q2 2024 and held it in 1 quarter. The position peaked at $36.4K in Q2 2024. 117 funds tracked by Wall St. Rank hold AQST as of Q3 2024.

  • Vontobel Holding reported no remaining Aquestive Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Vontobel Holding sold 14,000 Aquestive Therapeutics shares in Q3 2024, an estimated $36.4K.
  • Vontobel Holding first reported a position in Aquestive Therapeutics in Q2 2024 and held it in 1 quarter.
  • Vontobel Holding's Aquestive Therapeutics position peaked at $36.4K in Q2 2024.
  • 117 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q3 2024.

Based on Vontobel Holding's 13F filing for Q3 2024, filed 16 Oct 2024.